CagriSema: GI adverse events affected 79.6% in the CagriSema group vs 39.9% placebo in REDEFINE 1, including nausea, vomiting, diarrhea, constipation, and abd
Our portfolio of bispecifics has the potential to replace the first-generation checkpoint inhibitors across a range of cancers
This review offers an overview of the current advancements in research concerning the diverse mechanisms of mitochondrial damage associated with iron overload, with a particular emphasis on mitochondrial reactive oxygen species (mtROS) as a critical component linking the various pathways of damage
Nuclear ROS: a Trojan horse that induces DNA damage A new role of ROS related to transcriptional output has been recently highlighted
However, other factors can influence how well your body does this, even if you eat plenty of these foods
Moreover, HE staining analysis confirmed that no significant organ toxicity associated with this drug (Figure S17)